Tibor Docsa

2.1k citations

66 papers · 1.8k · h-index 24

Impact in

Organic Chemistry top 1%
- Carbohydrate Chemistry and Synthesis
- Click Chemistry and Applications
- Synthesis and biological activity
- Synthesis and Biological Evaluation
Rheumatology top 5%
- Glycogen Storage Diseases and Myoclonus

Papers in

Organic Chemistry 60
- Carbohydrate Chemistry and Synthesis 59
- Click Chemistry and Applications 13
Molecular Biology 50
- Biochemical and Molecular Research 25
- Glycosylation and Glycoproteins Research 22
- Chemical Synthesis and Analysis 4

Co-authors: Pál Gergely (51 shared papers)László Somsák (54 shared papers)Éva Bokor (20 shared papers)Véronika Nagy (7 shared papers)Zsuzsa Hadady (5 shared papers)Béla Tóth (5 shared papers)Marietta Tóth (9 shared papers)Sándor Kun (13 shared papers)
Journals: Carbohydrate Research (12 papers)Bioorganic & Medicinal Chemistry (11 papers)European Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)New Journal of Chemistry (3 papers)
Partner nations: Hungary Greece France

In The Last Decade

Tibor Docsa

66 papers receiving 1.7k citations

Peers

Countries citing papers authored by Tibor Docsa

Since Specialization

Citations

This map shows the geographic impact of Tibor Docsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tibor Docsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tibor Docsa more than expected).

Fields of papers citing papers by Tibor Docsa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tibor Docsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tibor Docsa. The network helps show where Tibor Docsa may publish in the future.

Co-authors

The 25 scholars most cited alongside Tibor Docsa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tibor Docsa Line = papers co-authored together Tibor Docsa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Glucose Analog Inhibitors of Glycogen Phosphorylases as Potential Antidiabetic Agents: Recent Developments Current Pharmaceutical Design ·László Somsák, Véronika Nagy, Zsuzsa Hadady, Tibor Docsa, Pál Gergely	2003	167
2	Synthesis of and a Comparative Study on the Inhibition of Muscle and Liver Glycogen Phosphorylases by Epimeric Pairs of d-Gluco- and d-Xylopyranosylidene-spiro-(thio)hydantoins and N-(d-Glucopyranosyl) Amides Journal of Medicinal Chemistry ·László Somsák, László Kovács, Marietta Tóth, Erzsébet Ősz, László Szilágyi, Zoltán Györgydeák, Zoltán Dinya, Tibor Docsa, Béla Tóth, Pál Gergely	2001	129
3	Kinetic and crystallographic studies on 2‐(β‐D‐glucopyranosyl)‐5‐methyl‐1, 3, 4‐oxadiazole, ‐benzothiazole, and ‐benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site Protein Science ·Evangelia D. Chrysina, Magda Kosmopoulou, Constantinos Tiraidis, R. Kardakaris, Nicolas Bischler, D.D. Leonidas, Zsuzsa Hadady, László Somsák, Tibor Docsa, Pál Gergely, Nikos G. Oikonomakos	2005	76
4	Synthesis of 1-(d-glucopyranosyl)-1,2,3-triazoles and their evaluation as glycogen phosphorylase inhibitors Bioorganic & Medicinal Chemistry ·Éva Bokor, Tibor Docsa, Pál Gergely, László Somsák	2009	73
5	Efficient inhibition of muscle and liver glycogen phosphorylases by a new glucopyranosylidene-spiro-thiohydantoin Bioorganic & Medicinal Chemistry Letters ·Erzsébet Ősz, László Somsák, László Szilágyi, László Kovács, Tibor Docsa, Béla Tóth, Pál Gergely	1999	69
6	Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition European Journal of Medicinal Chemistry ·David Goyard, Bálint Kónya, Aikaterini S. Chajistamatiou, Evangelia D. Chrysina, Jérémy Leroy, Sophie Balzarin, Michel Tournier, Didier Tousch, Pierre Petit, Cédric Duret, Patrick Maurel, László Somsák, Tibor Docsa, Pál Gergely, Jean‐Pierre Praly, Jacqueline Azay-Milhau, Sébastien Vidal	2015	63
7	Binding of N‐acetyl‐N ′‐β‐d‐glucopyranosyl urea and N‐benzoyl‐N ′‐β‐d‐glucopyranosyl urea to glycogen phosphorylase b European Journal of Biochemistry ·Nikos G. Oikonomakos, Magda Kosmopoulou, S.E. Zographos, D.D. Leonidas, Evangelia D. Chrysina, László Somsák, Véronika Nagy, Jean‐Pierre Praly, Tibor Docsa, Béla Tóth, Pál Gergely	2002	61
8	Synthesis and structure–activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase Bioorganic & Medicinal Chemistry ·Marietta Tóth, Sándor Kun, Éva Bokor, Mahmoud Benltifa, Gaylord Tallec, Sébastien Vidal, Tibor Docsa, Pál Gergely, László Somsák, Jean‐Pierre Praly	2009	58
9	In Search of Glycogen Phosphorylase Inhibitors: 5‐Substituted 3‐C‐Glucopyranosyl‐1,2,4‐oxadiazoles from β‐D‐Glucopyranosyl Cyanides upon Cyclization of O‐Acylamidoxime Intermediates European Journal of Organic Chemistry ·Mahmoud Benltifa, Sébastien Vidal, Bernard Fenêt, Moncef Msaddek, Peter G. Goekjian, Jean‐Pierre Praly, Attila Brunyánszki, Tibor Docsa, Pál Gergely	2006	57
10	Synthesis of N-(β-D-glucopyranosyl)- and N-(2-acetamido-2-deoxy-β-D-glucopyranosyl) amides as inhibitors of glycogen phosphorylase Bioorganic & Medicinal Chemistry ·Zoltán Györgydeák, Zsuzsa Hadady, Nóra Felföldi, Attila Krakomperger, Véronika Nagy, Marietta Tóth, Attila Brunyánszki, Tibor Docsa, Pál Gergely, László Somsák	2004	56
11	Synthesis of variously coupled conjugates of d-glucose, 1,3,4-oxadiazole, and 1,2,3-triazole for inhibition of glycogen phosphorylase Carbohydrate Research ·Sándor Kun, G. Nagy, Marietta Tóth, Laura Czecze, Albert Nguyen Van Nhien, Tibor Docsa, Pál Gergely, Maria-Despoina Charavgi, Paraskevi V. Skourti, Evangelia D. Chrysina, Tamás Patonay, László Somsák	2011	50
12	Kinetic and Crystallographic Studies of Glucopyranosylidene Spirothiohydantoin Binding to Glycogen Phosphorylase b Bioorganic & Medicinal Chemistry ·Nikos G. Oikonomakos, V.T. Skamnaki, Erzsébet Ősz, László Szilágyi, László Somsák, Tibor Docsa, Béla Tóth, Pál Gergely	2002	45
13	C-Glucopyranosyl-1,2,4-triazoles As New Potent Inhibitors of Glycogen Phosphorylase ACS Medicinal Chemistry Letters ·Éva Bokor, Tibor Docsa, Pál Gergely, László Somsák	2013	42
14	Glycogen phosphorylase inhibition improves beta cell function British Journal of Pharmacology ·Lilla Nagy, Judit Márton, András Vida, Gréta Kis, Éva Bokor, Sándor Kun, Mónika Gönczi, Tibor Docsa, Attila Tóth, Miklós Antal, Pál Gergely, Balázs Csóka, Pál Pacher, László Somsák, Péter Bai	2017	38
15	Glycogen Phosphorylase Inhibitor N-(3,5-Dimethyl-Benzoyl)-N’-(β-D-Glucopyranosyl)Urea Improves Glucose Tolerance under Normoglycemic and Diabetic Conditions and Rearranges Hepatic Metabolism PLoS ONE ·Lilla Nagy, Tibor Docsa, Magdolna Szántó, Attila Brunyánszki, Csaba Hegedűs, Judit Márton, Bálint Kónya, László Virág, László Somsák, Pál Gergely, Péter Bai	2013	36
16	New synthesis of 3-(β-D-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase European Journal of Medicinal Chemistry ·Sándor Kun, Éva Bokor, Gergely Varga, Béla Szőcs, András Páhi, Katalin Czifrák, Marietta Tóth, László Juhász, Tibor Docsa, Pál Gergely, László Somsák	2014	36
17	Synthetic, enzyme kinetic, and protein crystallographic studies of C -β- d -glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase European Journal of Medicinal Chemistry ·A.L. Kantsadi, Éva Bokor, Sándor Kun, G.A. Stravodimos, Demetra S.M. Chatzileontiadou, D.D. Leonidas, Éva Juhász‐Tóth, Andrea Szakács, Gyula Batta, Tibor Docsa, Pál Gergely, László Somsák	2016	35
18	4(5)-Aryl-2-C-glucopyranosyl-imidazoles as New Nanomolar Glucose Analogue Inhibitors of Glycogen Phosphorylase ACS Medicinal Chemistry Letters ·Éva Bokor, Sándor Kun, Tibor Docsa, Pál Gergely, László Somsák	2015	33
19	Glucose-based spiro-heterocycles as potent inhibitors of glycogen phosphorylase Bioorganic & Medicinal Chemistry ·Véronika Nagy, Mahmoud Benltifa, Sébastien Vidal, Eszter Berzsényi, Cathie Teilhet, Katalin Czifrák, Gyula Batta, Tibor Docsa, Pál Gergely, László Somsák, Jean‐Pierre Praly	2009	32
20	Gram-scale synthesis of a glucopyranosylidene-spiro-thiohydantoin and its effect on hepatic glycogen metabolism studied in vitro and in vivo Tetrahedron Asymmetry ·László Somsák, Véronika Nagy, Tibor Docsa, Béla Tóth, Pál Gergely	2000	30

About Tibor Docsa

Tibor Docsa is a scholar working on Organic Chemistry, Molecular Biology, Rheumatology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 66 papers that have together received 1.8k indexed citations. Recurring topics across this work include Carbohydrate Chemistry and Synthesis (59 papers), Biochemical and Molecular Research (25 papers), Glycogen Storage Diseases and Myoclonus (25 papers), Glycosylation and Glycoproteins Research (22 papers), Click Chemistry and Applications (13 papers), Pancreatic function and diabetes (6 papers), Enzyme Production and Characterization (5 papers) and Chemical Synthesis and Analysis (4 papers). The work is most often cited by research in Organic Chemistry (1.5k citations), Rheumatology (266 citations), Molecular Biology (1.1k citations), Biotechnology (99 citations) and Endocrinology, Diabetes and Metabolism (154 citations). Tibor Docsa has collaborated with scholars based in Hungary, Greece and France. Frequent co-authors include Pál Gergely, László Somsák, Éva Bokor, Véronika Nagy, Zsuzsa Hadady, Béla Tóth, Marietta Tóth, Sándor Kun, Jean‐Pierre Praly and Erzsébet Ősz. Their work appears in journals such as Carbohydrate Research, Bioorganic & Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and New Journal of Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Tibor Docsa

Impact in

Papers in i

In The Last Decade

Tibor Docsa

Peers

Countries citing papers authored by Tibor Docsa

Fields of papers citing papers by Tibor Docsa

All Works

About Tibor Docsa

Explore authors with similar magnitude of impact

Papers in